SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.110-7.7%Nov 6 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: 9wald9 who wrote (471)6/5/2006 8:17:04 AM
From: Mike McFarlandRead Replies (1) of 557
 
6/5/06 ENCOURAGING INTERIM RESULTS FROM A PHASE I/II TRIAL OF TARGETED GENETICS’ tgAAC94 IN PATIENTS WITH INFLAMMATORY ARTHRITIS

6/5/06 TARGETED GENETICS ENHANCES INFLAMMATORY ARTHRITIS PRODUCT DEVELOPMENT PLATFORM

6/5/06 TARGETED GENETICS AND COLLABORATORS ADVANCE KEY TECHNOLOGIES FOR AAV-BASED PRODUCT DEVELOPMENT

targen.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News